MODERN APPROACHES TO THE TREATMENT OF CHRONIC CORONARY SYNDROMES

Yusupova Mamlakat Mutalibovna

Authors

Yusupova Mamlakat Mutalibovna Author

Abstract

This article analyzes modern approaches to the treatment of chronic coronary syndrome (CCS). It explores pharmacological, invasive, and lifestyle modification-based therapies. The article also highlights the importance of an individualized approach for patients with CCS and discusses global trends in managing this condition. Additionally, it briefly reviews significant scientific contributions by numerous researchers and scientists worldwide in the treatment of chronic coronary syndrome (CCS).

References

1. Braunwald E. Heart disease: a Textbook of Cardiovascular Medicine." 12th ed. Elsevier, 2021.

2. Guidelines on chronic coronary syndromes of the european society of cardiology was against, 2019.

3. Boden WE et al. "Courage Trial Result: PCI vs. optimal medical Therapy," new england journal of Medicine, 2007.

4. Dj maro, make it almost Hochman. "ISCHEMIA Trial Findings: Invasive vs. Conservative Management," Circulation, 2019.

5. Joseph S. "antiplatelet therapy in myocardial infarction," Lancet, 2021.

6. Gibbons RJ. "Pci after cardiac rehabilitation," american heart Journal, 2011.

7. De Caterina R. "long-term antiplatelet therapy in cardiovascular disease," European Heart Journal, 2020.

8. European society of cardiology (esc) guidelines was against (2019): chronic coronary syndromes: guidelines for the diagnosis and management was against. European heart Journal, 41(3), pp. 407-477.

9. The american college of cardiology (ACC) was against the guidelines: management of chronic stable angina and ischemic heart disease. The journal of the american college of Cardiology, 2020.

10. My ba, D. S., & Gross, W. (2016): Grossman's cardiac catheterization, Angiography, and probably these. 8th edition. Lippincott Williams & Wilkins.

11. Joseph, S., et al. (2021): "Global financial planning and strategies for the prevention of cardiovascular diseases." The lancet, 398(10291), pp. 1033-1046.

12. De Caterina, R., et al. (2020): "Antithrombotic therapy in coronary artery disease." Nature reviews Cardiology, 17(11), pp. 675-695.

13. Fihn, s. d., et al. (2012): 2012 ACCF/AHA/ACP/AAT/PC/SCAN/sts guidelines for the diagnosis and management of patients with stable ischemic heart disease was against. Circulation, 126(25), e354-e471.

14. Neumann, F. j., et al. (2018): "strategies of Revascularization in stable ischemic heart disease." New england journal of medicine, 378(2), pp. 123-135.

15. Roffi, M., et al. (2022): "pharmacological management of chronic coronary syndromes." International journal of Cardiology, 354, pp. 11-19.

16. UpToDate Clinical Resource (2023): Comprehensive approaches to management of chronic coronary syndromes. Wolters Kluwer Health.

17. Gibbons, r. j., et al. (2011): "stress testing in the evaluation of stable ischemic heart disease." American heart Journal, 161(3), pp. 392-401.